Cardio Triple-Combo Drugs To Get FDA Panel Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Fixed combinations of an anti-hypertensive drug, aspirin and a statin will be the subject of an upcoming Cardiovascular and Renal Drugs Advisory Committee meeting, although no specific product is included on the agenda.